Clive Whitcher (Ph.D.)

Head of Patient Access at Mereo BioPharma

Clive Whitcher (Ph.D.) has a diverse and extensive work experience in the healthcare industry. Clive has held leadership positions in various companies, contributing to the commercialization and patient access of pharmaceutical products.

In 2001, Clive Whitcher started their career as a PhD Research Scientist at University College London, where they focused on fungal organisms and collaborated with industry partners.

Clive then worked at Whyte Chemicals Ltd as a Product Assistant, specializing in commodity chemicals and surfactants.

In 2005, Clive joined LGC Limited as a Research Scientist, responsible for setting up and commissioning a bioprocessing facility. Clive focused on biotechnology, bioengineering, and process optimization for biopharmaceutical processes.

After this, Clive worked as a Senior Analyst at PriceSpective and as a Senior Research Executive at Genactis, gaining experience in market analysis and research.

In 2011, Clive joined Double Helix Consulting (McCann Health) as a Director - Market Access, further expanding their expertise in the healthcare industry.

Following this, Clive joined Sobi - Swedish Orphan Biovitrum AB (publ) in 2014, where they held various roles, including Vice President: Head of Global Patient Access and Community Engagement. Clive was responsible for pricing strategies and patient access activities for the Sobi portfolio products.

In 2018, Clive joined Inceptua Group as the Vice President Head of Global Patient Access and later became the Executive Vice President - Head of Inceptua Pharma. Clive led the commercialization approach and was involved in asset evaluation, M&A, and in-licensing activities.

Most recently, in 2023, Clive joined Mereo BioPharma as the Head of Patient Access, continuing their focus on ensuring patient access to pharmaceutical products.

Overall, Clive Whitcher has a strong background in patient access, commercialization, and pricing strategies in the healthcare industry.

Clive Whitcher (Ph.D.) pursued their education with a strong focus on the field of Biochemical Engineering. Clive earned a Bachelor of Science degree in Biological & Medicinal Chemistry from the University of Exeter from 1998 to 2001. Continuing their academic journey, Clive attended UCL from 2001 to 2005, where they successfully completed a Ph.D. in Advanced Biochemical Engineering. Clive's educational background reflects their dedication to acquiring knowledge and expertise in the field of Biochemical Engineering.

Links

Previous companies

Inceptua Group logo

Timeline

  • Head of Patient Access

    June, 2023 - present

View in org chart